Citation: Cj. Knight, National Institute for Clinical Excellence guidance: too NICE to glycoprotein IIb/IIIa inhibitors?, HEART, 85(5), 2001, pp. 481-483
Authors:
Patel, DJ
Gomma, AH
Knight, CJ
Mulcahy, DA
Wright, CA
Purcell, HJ
Fox, KM
Citation: Dj. Patel et al., Why is recurrent myocardial ischaemia a predictor of adverse outcome in unstable angina? An observational study of myocardial ischaemia and its relation to coronary anatomy, EUR HEART J, 22(21), 2001, pp. 1991-1996
Authors:
Knight, CJ
Curzen, NP
Groves, PH
Patel, DJ
Goodall, AH
Wright, C
Clarke, D
Oldershaw, PJ
Fox, KM
Citation: Cj. Knight et al., Stent implantation reduces restenosis in patients with suboptimal results following coronary angioplasty, EUR HEART J, 20(24), 1999, pp. 1783-1790
Authors:
Goodall, AH
Curzen, N
Panesar, M
Hurd, C
Knight, CJ
Ouwehand, WH
Fox, KM
Citation: Ah. Goodall et al., Increased binding of fibrinogen to glycoprotein IIIa-Proline33 (HPA-1b, Pl(A2), Zw(b)) positive platelets in patients with cardiovascular disease, EUR HEART J, 20(10), 1999, pp. 742-747
Authors:
Gunning, MG
Anagnostopoulos, C
Davies, G
Knight, CJ
Pennell, DJ
Fox, KM
Pepper, J
Underwood, SR
Citation: Mg. Gunning et al., Simultaneous assessment of myocardial viability and function for the detection of hibernating myocardium using ECG-gated Tc-99(m)-tetrofosmin emission tomography: A comparison with Tl-201 emission tomography combined with cine magnetic resonance imaging, NUCL MED C, 20(3), 1999, pp. 209-214